Announcements Trials

Browse Landscape

Phase

Phase NA 3 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 3 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Follicular 2 Lymphoma 2 Leukemia 2 Hodgkin Disease 2 Waldenstrom Macroglobulinemia 1 Tissue Adhesions 1 Thrombocythemia, Essential 1 Sezary Syndrome 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycythemia Vera 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Pancreatic Neoplasms 1 Neutropenia 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Myoma 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Mycosis Fungoides 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoproliferative Disorders 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Myoma × Sodium Chloride × Clear all

NCT02166554 2014-06-18

BAP

BioRegen Biomedical (CHangzhou) Co., Ltd

Phase 1/2 Completed

Tissue Adhesions, Myoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡